BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31533277)

  • 21. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns.
    Conlin AMS; Bukowinski AT; Sevick CJ; DeScisciolo C; Crum-Cianflone NF
    Obstet Gynecol; 2013 Mar; 121(3):511-518. PubMed ID: 23635612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes - a historical cohort study.
    Cleary BJ; Rice Ú; Eogan M; Metwally N; McAuliffe F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():163-8. PubMed ID: 24793932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm.
    Andorf S; Bhattacharya S; Gaudilliere B; Shaw GM; Stevenson DK; Butte AJ; Sirota M
    J Reprod Immunol; 2019 Apr; 132():16-20. PubMed ID: 30852461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influenza vaccination of pregnant women and the experiences related to the pandemic influenza A-virus H1N1 infection in Hungary, 2009].
    Czeizel E
    Lege Artis Med; 2011 Feb; 21(2):89-95. PubMed ID: 21710706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.
    Gwon YD; Kim S; Cho Y; Heo Y; Cho H; Park K; Lee HJ; Choi J; Poo H; Kim YB
    PLoS One; 2016; 11(5):e0154824. PubMed ID: 27149064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.
    Low JG; Lee LS; Ooi EE; Ethirajulu K; Yeo P; Matter A; Connolly JE; Skibinski DA; Saudan P; Bachmann M; Hanson BJ; Lu Q; Maurer-Stroh S; Lim S; Novotny-Diermayr V
    Vaccine; 2014 Sep; 32(39):5041-8. PubMed ID: 25045806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pandemic A/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database.
    Beau AB; Hurault-Delarue C; Vidal S; Guitard C; Vayssière C; Petiot D; Montastruc JL; Damase-Michel C; Lacroix I
    Vaccine; 2014 Mar; 32(11):1254-8. PubMed ID: 24486369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
    Abzug MJ; Nachman SA; Muresan P; Handelsman E; Watts DH; Fenton T; Heckman B; Petzold E; Weinberg A; Levin MJ;
    Clin Infect Dis; 2013 May; 56(10):1488-97. PubMed ID: 23378284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy.
    Fisher BM; Van Bockern J; Hart J; Lynch AM; Winn VD; Gibbs RS; Weinberg A
    PLoS One; 2012; 7(3):e33048. PubMed ID: 22457731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
    Tunheim G; Laake I; Robertson AH; Waalen K; Hungnes O; Naess LM; Cox RJ; Mjaaland S; Trogstad L
    Influenza Other Respir Viruses; 2019 Mar; 13(2):191-200. PubMed ID: 30536590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.